Genmab and Bolt Biotherapeutics Announce Oncology Research and Development Collaboration

This exciting collaboration will provide a unique opportunity to combine Genmab’s innovative bispecific antibody technologies with Bolt’s powerful, advanced ISAC technology to develop targeted antibody products with the potential to transform cancer treatment

Continue Reading Genmab and Bolt Biotherapeutics Announce Oncology Research and Development Collaboration